Lista de obras -

Absence of CXCR4 mutations but high incidence of double mutant in CD79A/B and MYD88 in primary central nervous system lymphoma

scientific article published on 02 February 2015

Amplification of BCR-ABL rearrangement in atypical Philadelphia chromosome: a new variant detected by fluorescence in situ hybridization in one case of acute lymphoblastic leukemia

artículo científico publicado en 1999

Autoimmune hemolytic anemias and IgG antierythrocyte autoantibodies in Waldenström's macroglobulinemia: association with FcgammaRIIa polymorphism

artículo científico publicado en 2006

Balancing risk versus benefit in the treatment of Waldenström's Macroglobulinemia patients with nucleoside analogue-based therapy

artículo científico publicado en 2009

CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder

artículo científico publicado en 2015

Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia

artículo científico publicado en 2008

Expression of lung resistance protein and correlation with other drug resistance proteins and outcome in myelodysplastic syndromes.

artículo científico publicado en 1998

Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia.

artículo científico publicado en 2013

Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia

artículo científico publicado en 2015

Genomic studies have identified multiple mechanisms of genetic changes in Waldenström macroglobulinemia.

artículo científico publicado en 2013

Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome

artículo científico publicado en 2016

High-throughput genomic analysis in Waldenström's macroglobulinemia

scientific article published on February 2011

Increased trisomy 12 frequency and a biased IgVH 3-21 gene usage characterize small lymphocytic lymphoma.

artículo científico publicado en 2009

Is ZAP-70 expression stable over time in B chronic lymphocytic leukaemia?

artículo científico publicado en 2007

JAK2 V617F mutation is absent in chronic lymphocytic leukemia

artículo científico publicado en 2006

Lenalidomide is safe and active in Waldenström macroglobulinemia.

artículo científico publicado en 2015

Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström macroglobulinemia.

artículo científico publicado en 2015

MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome

artículo científico publicado en 2014

MYD88 L265P mutation in Waldenstrom macroglobulinemia.

artículo científico publicado en 2013

Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia

artículo científico publicado en 2016

Role of IRF4 in resistance to immunomodulatory (IMid) compounds® in Waldenström's macroglobulinemia.

artículo científico publicado en 2017

TCL1 expression patterns in Waldenström macroglobulinemia

artículo científico publicado en 2015

TOP3A, a new partner gene fused to MLL in an adult patient with de novo acute myeloid leukaemia

article

TP53 mutation and its prognostic significance in Waldenstrom's Macroglobulinemia

artículo científico publicado en 2017

The IL6(-174G/C) polymorphism is a prognostic factor for survival after treatment initiation in Waldenstrom macroglobulinemia patients aged 65 years or less

scientific article published on 27 May 2008

The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma

artículo científico publicado en 2016

Waldenström's macroglobulinemia

artículo científico publicado en 2010

Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia: C-X-C Chemokine Receptor Type 4 Mutation and Beyond

artículo científico publicado en 2018

Lista de obras de

Absence of CXCR4 mutations but high incidence of double mutant in CD79A/B and MYD88 in primary central nervous system lymphoma

Amplification of BCR-ABL rearrangement in atypical Philadelphia chromosome: a new variant detected by fluorescence in situ hybridization in one case of acute lymphoblastic leukemia

Autoimmune hemolytic anemias and IgG antierythrocyte autoantibodies in Waldenström's macroglobulinemia: association with FcgammaRIIa polymorphism

Balancing risk versus benefit in the treatment of Waldenström's Macroglobulinemia patients with nucleoside analogue-based therapy

CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder

Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia

Expression of lung resistance protein and correlation with other drug resistance proteins and outcome in myelodysplastic syndromes.

Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia.

Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia

Genomic studies have identified multiple mechanisms of genetic changes in Waldenström macroglobulinemia.

Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome

High-throughput genomic analysis in Waldenström's macroglobulinemia

Increased trisomy 12 frequency and a biased IgVH 3-21 gene usage characterize small lymphocytic lymphoma.

Is ZAP-70 expression stable over time in B chronic lymphocytic leukaemia?

JAK2 V617F mutation is absent in chronic lymphocytic leukemia

Lenalidomide is safe and active in Waldenström macroglobulinemia.

Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström macroglobulinemia.

MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome

MYD88 L265P mutation in Waldenstrom macroglobulinemia.

Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia

Role of IRF4 in resistance to immunomodulatory (IMid) compounds® in Waldenström's macroglobulinemia.

TCL1 expression patterns in Waldenström macroglobulinemia

TOP3A, a new partner gene fused to MLL in an adult patient with de novo acute myeloid leukaemia

TP53 mutation and its prognostic significance in Waldenstrom's Macroglobulinemia

The IL6(-174G/C) polymorphism is a prognostic factor for survival after treatment initiation in Waldenstrom macroglobulinemia patients aged 65 years or less

The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma

Waldenström's macroglobulinemia

Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia: C-X-C Chemokine Receptor Type 4 Mutation and Beyond